Xeomin
Xeomin 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Episodic Migraine、Chronic Migraine。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
22 项
全球在招研究
10 项
已进入 III/IV 期
11 个
开展国家和地区
暂未检索到
中国境内设点
药品与企业信息
研发企业
- Merz Therapeutics GmbH
- Assistance Publique - Hôpitaux de Paris
- Hospices Civils de Lyon
- University of Miami
- Alain Kaelin
- Uniformed Services University of the Health Sciences
- Wake Forest University Health Sciences
- Nantes University Hospital
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
- Merz North America, Inc.
- Merz Pharmaceuticals, LLC
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
法国、美国、瑞士、荷兰、South Korea、Pakistan、英国、比利时、丹麦、Luxembourg、Russia
正在招募患者的 Xeomin 研究
Surgery with Botulinum Toxin a for Incisional Hernia
III 期招募中法国NCT06499324Evaluation of Tibial Nerve Selective Neurotomy Compared to Botulinum Toxin Injections for Spastic Foot Treatment in Post-stroke Patients According to a Goal-centered Approach
不适用招募中法国NCT05874154Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A)
II 期招募中美国NCT06293300DEgenerative ROtator Cuff Disease and Botulinum TOXin
II 期招募中法国NCT05327972IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia
III 期招募中瑞士NCT03977493Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents
不适用招募中美国NCT07267819Xeomin® and Gait Related Mobility After Stroke
IV 期招募中美国NCT04908423Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea
III 期招募中法国NCT06995287Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
IV 期招募中荷兰NCT06448676To Evaluate HU-045 With Moderate to Severe Glabellar Lines
III 期招募中South KoreaNCT07870694DaxibotulinumtoxinA for Blepharospasm
II 期招募中美国NCT07489430Clinical Evaluation of Botulinum Toxin a in the Management of Temporomandibular Myofascial Pain
II 期招募中PakistanNCT07847541Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy
II 期招募中美国NCT03571334Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities
IV 期招募中英国NCT07303582To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)
III 期招募中South KoreaNCT06205797Pilot Study on Muscle, Tendon, and Neural Changes Post-Botulinum Toxin Injections in Post-stroke Spastic Equinovarus
不适用招募中比利时NCT06767631Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study
不适用招募中丹麦NCT07473635RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder
II 期招募中美国NCT07553065BOTOX® vs. XEOMIN® for Chronic Migraine
III 期招募中美国NCT05598723IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction
II 期招募中美国NCT07486830Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment
不适用招募中LuxembourgNCT06782464Complex Treatment of a Chronic Anal Fissure
IV 期招募中RussiaNCT03855046
中国患者怎么争取用上这款药
目前境内暂未检索到设点，下面几条途径是更现实的选择，每条都有详细的中文做法。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。